WallStreetZenWallStreetZen

AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Bottom 3%
#4435 out of 4527 analysts
Average Return
-13.5%
Win Rate
36%10 out of 28
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inovio Pharmaceuticals IncINO
+89.67%$6.87$13.03
2024-01-04 -
2024-03-27
Buy
Pardes Biosciences IncPRDS
+81.51%$1.19$2.16
2022-12-13 -
2023-08-30
Buy
Enanta Pharmaceuticals IncENTA
+65.80%$9.97$16.53
2023-11-21 -
2024-03-27
Buy
Pardes Biosciences IncPRDS
+60.00%$1.35$2.16
2023-03-15 -
2023-08-30
Buy
Dynavax Technologies CorpDVAX
+36.27%$10.45$14.24
2022-09-27 -
2023-09-26
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Gritstone Bio IncGRTS
1Buy$4.00+42.86%Initiates Coverage On
a month ago
Inovio Pharmaceuticals IncINO
1Buy$12.00-7.90%Initiates Coverage On
3 months ago
An2 Therapeutics IncANTX
1Buy$30.00+831.68%Initiates Coverage On
3 months ago
Enanta Pharmaceuticals IncENTA
6Buy$23.00+39.14%Maintains
4 months ago
Dynavax Technologies CorpDVAX
5Buy$27.00+117.57%Maintains
5 months ago
Arbutus Biopharma CorpABUS
3Buy$6.00+130.77%Reiterates
9 months ago
Curevac NvCVAC
4Buy$24.00+686.89%Maintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
a year ago
Esperion Therapeutics IncESPR
1Buy$15.00N/AReiterates
a year ago
Argenx SeARGX
2Buy$448.00N/AMaintains
a year ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
a year ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
2 years ago
Polypid LtdPYPD
1Buy$420.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.